RT

Rachel Tsunemoto Hislop

Principal, Director of Research at Two Bear Capital | Neuroscientist

San Diego, California

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Rachel

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

TB
Two Bear Capital

2020

  • Principal, Director of Research

    2024

  • Principal

    2020 - 2024

AT
Abilita Therapeutics, Inc.

2022 - 2024

  • Board Observer

    2022 - 2024

NB
Novoron Bioscience

2021 - 2024

  • Board Observer

    2021 - 2024

Acorda Therapeutics, Inc.

2017 - 2020

  • Medical Science Liaison

    2017 - 2020

US
UC San Diego Health

2016 - 2017

  • Stem Cell and Molecular Biology Researcher

    2016 - 2017

    Ph.D. researcher working with Dr. Lawrence Goldstein and Dr. Samuel Pfaff

Freelance

2013 - 2016

  • Science Communicator

    2013 - 2016

US
UC San Diego

2010 - 2016

  • Neuroscience Ph.D. Candidate and Research Associate

    2010 - 2016

    Neuroscience Ph.D. student (graduated March 2016) working with Dr. Kristin Baldwin (The Scripps Research Institute).

M
MIT

2008 - 2009

  • Undergraduate Research Assistant

    2008 - 2009

    Undergraduate student working with Dr. Li-Huei Tsai.

M(
Merck (Neuroscience Drug Discovery Department)

2007 - 2007

  • Summer Research Intern

    2007 - 2007